BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

RSV-F vaccine: Phase I started

Novavax began a double-blinded, placebo-controlled, dose-escalation, U.S. Phase I trial to evaluate 5, 15 and 30 µg intramuscular RSV-F vaccine in 100 healthy volunteers. Last month,...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >